Post by : Shakul
Singapore has declared a significant US$12 million funding boost to the Coalition for Epidemic Preparedness Innovations (CEPI) as part of its unwavering commitment to enhance worldwide pandemic readiness and vaccine development capabilities. The financial support will be spread out over a span of four years, specifically from 2027 to 2030.
This decisive announcement was made by Singapore's Health Minister Ong Ye Kung during a CEPI event held in conjunction with the 79th World Health Assembly in Geneva, Switzerland. Officials underscored that this contribution symbolizes Singapore's long-standing dedication to promoting global collaboration in public health and disease prevention efforts.
According to the Ministry of Health, vaccines are essential for effectively managing infectious disease outbreaks and potential future pandemics. The ministry emphasized that robust international partnerships are vital for ensuring that vaccines can be developed and distributed swiftly during global health emergencies.
Since partnering with CEPI in 2020, Singapore has actively supported the organization's international vaccine initiatives. Authorities noted that this continued collaboration has fortified Singapore's own vaccine R&D, manufacturing capacities, scientific advisory systems, and regulatory preparedness.
Minister Ong highlighted the substantial investments Singapore has made in vaccine research and healthcare innovation in recent years. He remarked that collaboration with CEPI has not only enhanced Singapore's scientific proficiency but has also contributed to broader global public health initiatives.
The newly allocated funds are anticipated to bolster CEPI's mission to expedite vaccine research and guarantee fair access to vaccines during forthcoming outbreaks. CEPI collaborates with various governments, research entities, and pharmaceutical firms globally to better global epidemic response strategies.
Global health authorities have continuously emphasized the need for reinforced preparedness measures following the insights gained from the COVID-19 crisis. Nations are increasingly focusing on vaccine security, medical supply chains, and international health coordination to mitigate the risks posed by future disease outbreaks.
Singaporean officials reaffirmed their commitment to actively contribute to enhancing global healthcare resilience while supporting international frameworks aimed at swiftly addressing emerging infectious diseases.
English
